Renaissance Capital logo

CCCC News

US IPO Weekly Recap: IPOs, SPACs, and direct listings, oh my!

PLTR

A total of 29 companies entered the public market this past week, the most ever in a single week. The week’s 11 IPOs were joined by 15 SPACs and three direct listings. Notable new IPO filings included TPG-backed antivirus provider ...read more

Preclinical oncology biotech C4 Therapeutics prices upsized IPO above the range at $19

C4 Therapeutics logo

C4 Therapeutics, a preclinical biotech developing small molecule protein degraders to treat cancer, raised $182 million by offering 9.6 million shares at $19, above the range of $16 to $18. The company offered 0.8 million more shares than anticipated. At pricing...read more

Preclinical oncology biotech C4 Therapeutics sets terms for $150 million IPO

C4 Therapeutics logo

C4 Therapeutics, a preclinical biotech developing small molecule protein degraders to treat cancer, announced terms for its IPO on Monday. The Watertown, MA-based company plans to raise $150 million by offering 8.8 million shares at a price range of $16 to...read more

US IPO Weekly Recap: IPO launches and filings abound in the post-Labor Day frenzy

LSPD

One IPO and nine SPACs went public this past week. Thirteen IPOs and eleven SPACs submitted initial filings as the IPO market gears up for a busy September.  Canadian cloud-based POS software provider Lightspeed POS (LSPD)...read more